Company Overview
CURE Pharmaceutical is a vertically integrated drug delivery and development company committed to improving drug efficacy, safety and the patient experience through its proprietary drug dosage forms and delivery systems. CURE has a full-service cGMP manufacturing facility and is a pioneering developer and manufacturer of a patented and proprietary delivery system (CUREfilm™), one of the most advanced oral thin film (OTFs) on the market today. CURE is developing a pipeline of CUREfilm™ products partnering with lifestyle brands as well as biotech and pharmaceutical companies. CURE has positioned itself to advance numerous therapeutic categories, including the pharmaceutical cannabis sector with partnerships in the U.S., Canada and Israel. The company’s mission is to improve people’s lives by redefining how medicines are delivered and experienced.
About CURE Pharmaceutical
- HQ Location
- Oxnard, CA
- Founded
- 2011
- Ownership
- public
- Industry
- CBD,Medical Focus
- Social
- Facebook, Twitter, Instagram, Linkedin
Related Franchise Content
Business News
Planet Fitness Is Increasing Membership Prices for the First Time in Nearly 30 Years
The gym chain's classic membership has traditionally been $10 since 1998.
Franchise
The IFA Just Released Guidelines to Combat an Industry-Wide Problem. Here's What it Means For Businesses.
The guidelines, part of the responsible franchising initiative, are aimed at strengthening and expanding the franchise industry and franchising model via increased transparency.
Franchise
After Months of Scrutiny, Roark Capital Finalizes $9.6 Billion Subway Acquisition
The sale, initially announced in August 2023, was delayed by Federal Trade Commission scrutiny.